SCHEMBL3213867

SCHEMBL3213867

O=S(=O)(c1ccccc1Cl)N1CCC(c2ncccc2C(F)(F)F)CC1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 2/20 0.51
MEN1 O00255 1/20 0.51
HSD11B1 P28845 6/20 0.51
TRPV1 Q8NER1 1/20 0.47
CNR1 P21554 1/20 0.45
HTR2A P28223 1/20 0.44
HTR2C P28335 1/20 0.44
FAAH O00519 2/20 0.44
HDAC3 O15379 1/20 0.43
HDAC4 P56524 1/20 0.43
HDAC1 Q13547 1/20 0.43
HDAC7 Q8WUI4 1/20 0.43
HDAC2 Q92769 1/20 0.43
HDAC10 Q969S8 1/20 0.43
HDAC11 Q96DB2 1/20 0.43
HDAC8 Q9BY41 1/20 0.43
HDAC6 Q9UBN7 1/20 0.43
HDAC9 Q9UKV0 1/20 0.43
HDAC5 Q9UQL6 1/20 0.43
POLB P06746 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3198998 0.87 TRPV1 (0.48) KMT2AMEN1HSD11B1TRPV1CNR1
SCHEMBL3212924 0.84 HSD11B1 (0.65) HSD11B1TRPV1
SCHEMBL3215950 0.82 FAAH (0.48) FAAHHDAC3HDAC4HDAC1HDAC7
SCHEMBL3224328 0.82 HSD11B1 (0.67) KMT2AMEN1HSD11B1TRPV1POLB
SCHEMBL13489663 0.81 TRPV1 (0.53) KMT2AHSD11B1TRPV1POLB
SCHEMBL3205481 0.80 HSD11B1 (0.67) KMT2AMEN1HSD11B1TRPV1
SCHEMBL3213922 0.79 HSD11B1 (0.67) KMT2AMEN1HSD11B1POLBMAPT
SCHEMBL3213850 0.79 HSD11B1 (0.78) HSD11B1
SCHEMBL5439348 0.76 HSD11B1 (0.72) HSD11B1
SCHEMBL1690182 0.74 TRPV1 (0.53) HSD11B1TRPV1HTR2C

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100029648-A1 11-Beta HSD1 Inhibitors XIANG JASON SHAOYUN 2010-02-04 US disclosed
US-7632838-B2 11-beta HSD1 inhibitors WYETH (US) 2009-12-15 US disclosed
EP-1981848-A2 11-BETA HSD1 INHIBITORS Wyeth (US) 2008-10-22 EP disclosed
US-20070219198-A1 11-Beta HSD 1 inhibitors WYETH (US) 2007-09-20 US disclosed
WO-2007092435-A2 11-BETA HSD1 INHIBITORS WYETH (US) 2007-08-16 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100029648-A1 11-Beta HSD1 Inhibitors HSD11B1, HSD3B1, HSD11B2 KMT2A 1609/4885MEN1 1354/4885HSD11B1 1/4885
US-20070219198-A1 11-Beta HSD 1 inhibitors HSD11B1, HSD11B2, HSD3B1 KMT2A 1591/4885MEN1 1687/4885HSD11B1 1/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.